Of note, mice deficient in TG-2 develop systemic autoimmunity with splenomegaly and glomerulonephritis due to impaired clearance of apoptotic cells during thymus involution, which should prompt further investigation of the possible side effects of TG-2 inhibition [91]. The gene discussed is TGM2; the disease is Splenomegaly.